Table 1: Patient demographics.

AgeBMI
before
BMI
after
Types of tumorType of
reconstruction
Time from
mastectomy to fat graft
Graft
follow-up
Time between
MRIs
RTX

Stem group
15524,224,0LCILD + IMPL3 y 8 m4 y 1 m12 mYes
24725,425,8MucinousLD + IMPL3 y 9 m3 y 9 m11 mYes
34928,027,6DCIEXP + IMPL3 y 2 m3 y 2 m15 mNo
44827,227,6DCILD + IMPL3 y 7 m3 y 2 m15 mYes
55128,728,7DCIEXP + IMPL2 y 6 m3 y 1 m13 mNo
64127,529,1DCISTRAM4 y 10 m3 y 1 m16 mYes
75424,025,1DCILD + IMPL3 y2 y 10 m13 mYes
84423,523,3DCILD + IMPL4 y 1 m2 y 9 m16 mYes
95623,923,9DCITRAM4 y2 y 9 m19 mYes
105825,625,6NontumorNo reconstruction20 y2 y 6 m13 mNo
114330,929,7LCISeq explantation4 y 1 m1 y 8 m17 mYes

Average5 y 2 m36 m14,5 m72,7%

Control group
15129,229,2DCIEXP + IMPL3 y 2 m2 y 6 m16 mNo
24020,820,4MedullarEXP + IMPL3 y 1 m1 y 11 m19 mNo
35632,432,6DCISeq explantation7 y 3 m1 y 9 m19 mYes
46925,928,1DCISLD + IMPL16 y 6 m1 y 3 m13 mYes
53824,126,1DCILD + IMPL2 y 5 m1 y 1 m11 mYes
63624,123,2DCILD + IMPL8 y 3 m1 y11 mYes
75925,625,2LCIEXP + IMPL5 y 8 m8 m7 mNo
84924,924,3DCISSeq explantation2 y 8 m8 m7 mYes

Average6 y 1 m16 m12,9 m62,5%

values0.9770.7650.861nmnmnmnm0.414>0.999

BMI, body mass index; LD, latissimus dorsi; Impl, implant; Seq, sequelae; DCI, ductal carcinoma invasive; DCIS, ductal carcinoma in situ; LCI, lobular carcinoma invasive; Exp, expander; m, months; RTX, radiotherapy; nm, not measured; y, years.